StockMarketWire.com - Tiziana Life Sciences has expanded its executive team with the appointment of James Tripp as chief operating officer and head of global clinical operations.

Tripp, who will be responsible for all operations, including global clinical development for the Company, is not being appointed to the plc board. Tripp has more than 20 years' experience in biopharmaceutical operations and has been involved in all phases of drug development from discovery through commercialisation.


At 2:12pm: [LON:TILS] Tiziana Life Sciences Plc Ord 3p share price was +8.38p at 210.88p



Story provided by StockMarketWire.com